CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?

Skip to the main content

Physical and Rehabilitation Medicine, Vol. 40 No. 1, 2026.

Meeting abstract

https://doi.org/10.21751/FRM-40-1-24

CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?

Jasmina Ćatić *
Dijana Bešić
Marin Viđak
Šime Manola
Ivana Jurin

* Corresponding author.

Full text: croatian pdf 81 Kb

page 103-105

downloads: 99

APA 6th Edition

Ćatić, J., Bešić, D., Viđak, M., Manola, Š. & Jurin, I. (2026). CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?. Fizikalna i rehabilitacijska medicina, 40 (1), 105-106. https://doi.org/10.21751/FRM-40-1-24

MLA 8th Edition

Ćatić, Jasmina, et al. "CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?." Fizikalna i rehabilitacijska medicina, vol. 40, no. 1, 2026, pp. 105-106. https://doi.org/10.21751/FRM-40-1-24. Accessed 11 Jul. 2026.

Chicago 17th Edition

Ćatić, Jasmina, Dijana Bešić, Marin Viđak, Šime Manola and Ivana Jurin. "CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?." Fizikalna i rehabilitacijska medicina 40, no. 1 (2026): 105-106. https://doi.org/10.21751/FRM-40-1-24

Harvard

Ćatić, J., et al. (2026). 'CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?', Fizikalna i rehabilitacijska medicina, 40(1), pp. 105-106. https://doi.org/10.21751/FRM-40-1-24

Vancouver

Ćatić J, Bešić D, Viđak M, Manola Š, Jurin I. CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?. Fizikalna i rehabilitacijska medicina [Internet]. 2026 [cited 2026 July 11];40(1):105-106. https://doi.org/10.21751/FRM-40-1-24

IEEE

J. Ćatić, D. Bešić, M. Viđak, Š. Manola and I. Jurin, "CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?", Fizikalna i rehabilitacijska medicina, vol.40, no. 1, pp. 105-106, 2026. [Online]. https://doi.org/10.21751/FRM-40-1-24

Abstract

Keywords

obesity, GLP-1 receptor agonist, semaglutide

Hrčak ID:

345475

URI

https://hrcak.srce.hr/345475

Publication date:

5.3.2026.

Article data in other languages: croatian

Visits: 381 *